Skip to main content
Edward Kim, MD, Oncology, Sacramento, CA, UC Davis Medical Center

EdwardJae HoonKimMDPhD

Oncology • Sacramento, CA

Gastrointestinal Cancer

Associate Professor of Medicine Medical Director - Office of Clinical Research Medical Director - Cancer Care Network Associate Director - MD/PhD Program UC Davis Comprehensive Cancer Center

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Summary

  • Dr. Edward Kim is a medical oncology physician scientist at the UC Davis Comprehensive Cancer Center where he specializes in gastrointestinal malignancies. He graduated from Harvard University and received his MD/PhD from Stony Brook University School of Medicine and has been in practice 12 years.

    • Advanced Pancreatic Cancer and Molecular Testing

    Transcript: John Marshall, MD: We are making significant breakthroughs in understanding the biology of pancreatic adenocarcinoma and refining the use the use of

    Practical Considerations for Pancreatic Cancer Genetic Testing

    Transcript: John Marshall, MD: Paul, our lung cancer colleagues are very used to doing liquid biopsies. It's one of their standards, even as a primary diagnosis

    Genomic Testing in Pancreatic Cancer

    Transcript: John Marshall, MD: I want to take what you just reviewed apart, because a lot of us are playing catch-up on understanding these molecular reports. Y

    Changing Role of Surgery in Pancreatic Cancer

    The role of neoadjuvant therapy and the importance of multidisciplinary assessment for patients with advanced pancreatic adenocarcinoma.

    Pancreatic Cancer Adjuvant Therapy

    Transcript: John Marshall, MD: I went through a phase where, yes, surgery was exciting. Then I went through a fairly large part of my career where I thought, "W

    Borderline Resectable Pancreatic Cancer

    Transcript: John Marshall, MD: Let's just remind everybody off-script: You have a patient with pancreatic cancer. They get diagnosed by a scan done for some rea

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2011
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 2005 - 2007
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2005
  • Harvard University
    Harvard UniversityAB, Chemistry, Magna cum laude, 1993 - 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • MI State Medical License
    MI State Medical License 2005 - 2015
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • $3 Million National Grant to Fund Pancreatic Cancer Study
    $3 Million National Grant to Fund Pancreatic Cancer StudyFebruary 7th, 2023

Hospital Affiliations

Dr. Edward Kim, Dr. Edward Kim, MD, Dr. E Kim, Dr. Edward Jae Hoon Kim